Jacobio Pharmaceuticals repurchases shares, increasing treasury holdings

On October 20, 2025, Jacobio Pharmaceuticals Group Co., Ltd. repurchased 126,900 of its ordinary shares on the Exchange. The shares were bought at prices ranging from HK$7.8 to HK$7.9, for a total of HK$996,972. This transaction increased the number of treasury shares by 126,900, bringing the total to 3,608,100 shares.

Following the repurchase, the number of issued shares excluding treasury shares decreased by 126,900 to 788,146,980. The repurchase represents 0.0161% of the existing number of issued shares (excluding treasury shares) prior to the event. The total number of issued shares for the company remains at 791,755,080.

The repurchase was made under a mandate granted on June 10, 2025, which authorized the repurchase of up to 78,873,528 shares. To date, the company has repurchased 588,300 shares, representing 0.0746% of the issued shares (excluding treasury shares) as of the mandate date. A moratorium period for new share issues or sales/transfers of treasury shares is in effect until November 19, 2025.